| Financial Year |
March 31 2023 |
| Monetary Funds |
248,253,846.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
42,424,060.28 |
| Accounts Receivable |
228,342,142.95 |
| Advances to Suppliers |
52,897,744.22 |
| Other Receivables |
58,378,461.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
53,200,000.00 |
| Inventories |
337,811,360.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,465,963.00 |
| Total Current Assets |
982,645,744.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
628,835,679.66 |
| Investment Properties |
9,220,308.80 |
| Fixed Assetes |
238,319,370.63 |
| Under-construction Projects |
51,615,692.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,947,589.36 |
| R&D expenses |
26,806,459.25 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
42,999.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,041,052,711.66 |
| Total Assets |
2,023,698,456.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,993,567.50 |
| Accounts Payable |
95,624,909.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,536,151.13 |
| Taxes Payable |
3,227,250.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,052,164.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
31,504,060.28 |
| Sub-Total of Current Liabilities |
235,642,680.11 |
| Long-term Loans |
150,780,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,427,639.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,000,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
220,007,854.29 |
| Total Liabilities |
455,650,534.40 |
| Paid-In Capital(Or Share Stock) |
440,832,644.00 |
| Capital Surplus |
1,231,777,810.11 |
| Surplus Reserve |
238,372,318.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-359,345,006.41 |
| Minority Stockholder's Interest |
10,749,765.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,557,298,156.05 |
| Owner's Equity（Stockholder's Equity） |
1,568,047,921.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,023,698,456.03 |
